LLY

998.88

-0.19%↓

JNJ

243.11

-0.23%↓

ABBV

227.62

+0.42%↑

NVS

155.44

-3.77%↓

AZN

192.99

-1.1%↓

LLY

998.88

-0.19%↓

JNJ

243.11

-0.23%↓

ABBV

227.62

+0.42%↑

NVS

155.44

-3.77%↓

AZN

192.99

-1.1%↓

LLY

998.88

-0.19%↓

JNJ

243.11

-0.23%↓

ABBV

227.62

+0.42%↑

NVS

155.44

-3.77%↓

AZN

192.99

-1.1%↓

LLY

998.88

-0.19%↓

JNJ

243.11

-0.23%↓

ABBV

227.62

+0.42%↑

NVS

155.44

-3.77%↓

AZN

192.99

-1.1%↓

LLY

998.88

-0.19%↓

JNJ

243.11

-0.23%↓

ABBV

227.62

+0.42%↑

NVS

155.44

-3.77%↓

AZN

192.99

-1.1%↓

Search

ICU Medical Inc

Открыт

СекторЗдравоохранение

133.54 0.6

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

128.46

Макс.

133.98

Ключевые показатели

By Trading Economics

Доход

-12M

-16M

Продажи

3.3M

540M

P/E

Средняя по отрасли

4,444.667

61.417

Прибыль на акцию

1.91

Рентабельность продаж

-2.912

Сотрудники

13,000

EBITDA

-5.8M

61M

Рекомендации

By TipRanks

Рекомендации

Покупка

Прогноз на 12 месяцев

+34.24% upside

Дивиденды

By Dow Jones

Следующий отчет о доходах

7 мая 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-285M

3.3B

Предыдущая цена открытия

132.94

Предыдущая цена закрытия

133.54

Новостные настроения

By Acuity

23%

77%

41 / 351 Рейтинг в Healthcare

Техническая оценка

By Trading Central

Уверенность

Very Strong Bullish Evidence

ICU Medical Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

10 мар. 2026 г., 20:38 UTC

Отчет

Oracle Raises 2027 Sales Outlook Amid AI Demand, Restructuring

10 мар. 2026 г., 23:57 UTC

Обсуждения рынка

Global Equities Roundup: Market Talk

10 мар. 2026 г., 23:57 UTC

Обсуждения рынка

Risks Rising on Australian Bank Valuation Multiples -- Market Talk

10 мар. 2026 г., 23:47 UTC

Обсуждения рынка

Nikkei May Rise as Concerns About Energy Costs Ease -- Market Talk

10 мар. 2026 г., 23:37 UTC

Приобретения, слияния, поглощения

Yangzijiang Shipbuilding to Acquire Poseidon Stake for US$825.7M

10 мар. 2026 г., 23:37 UTC

Приобретения, слияния, поглощения

Yangzijiang Shipbuilding to Buy 10% Stake in Poseidon

10 мар. 2026 г., 23:37 UTC

Приобретения, слияния, поглощения

Yangzijiang Shipbuilding to Fund Deal With Internal Cash Resources

10 мар. 2026 г., 23:37 UTC

Приобретения, слияния, поглощения

Yangzijiang Shipbuilding to Buy Stake From Fairfax, Washington Family Affiliates

10 мар. 2026 г., 23:35 UTC

Обсуждения рынка
Главные новостные события

Gold Edges Higher as It Faces Opposing Forces -- Market Talk

10 мар. 2026 г., 23:06 UTC

Отчет

Oracle Raises 2027 Sales View as AI Demand Outpaces Supply -- Update

10 мар. 2026 г., 22:51 UTC

Главные новостные события

Deleted Tweet From Energy Secretary Sends Oil Markets on Another Wild Ride -- Updated

10 мар. 2026 г., 21:39 UTC

Приобретения, слияния, поглощения

Bill Ackman Has a Stroke of Genius. Buy His New Fund and Get Shares of His Pershing Square IPO. -- Barrons.com

10 мар. 2026 г., 21:21 UTC

Отчет

Oracle Stock Jumps on Earnings Beat. Its Cloud Business Is Taking Over. -- Barrons.com

10 мар. 2026 г., 21:15 UTC

Отчет

Franco-Nevada: 2026 Total GEOs Expected to Range From 510,000 to 570,000 Ounces

10 мар. 2026 г., 21:15 UTC

Приобретения, слияния, поглощения

Paramount Skydance's Stock Fades. The Warner Bros. Merger Will Take Years to Pay Off, BofA Says. -- Barrons.com

10 мар. 2026 г., 21:14 UTC

Отчет

Franco-Nevada: Methodology Replaces Previous Variable GEO Conversion Ratios Based on Prevailing Market Prices

10 мар. 2026 г., 21:13 UTC

Отчет

Franco-Nevada: Beginning in 2026, Company Will Be Adopt Fixed GEO Conversion Ratios Based on the Pricing Assumptions Outlined in 2026 Guidance

10 мар. 2026 г., 21:12 UTC

Отчет

Franco-Nevada 4Q Rev $597.3M >FNV

10 мар. 2026 г., 21:12 UTC

Отчет

Franco-Nevada 4Q EPS $1.90

10 мар. 2026 г., 20:57 UTC

Отчет

Oracle Stock Jumps on Earnings Beat -- Barrons.com

10 мар. 2026 г., 20:50 UTC

Обсуждения рынка
Отчет

Tech, Media & Telecom Roundup: Market Talk

10 мар. 2026 г., 20:44 UTC

Отчет

Oracle Stock Jumps on Earnings Beat -- Barrons.com

10 мар. 2026 г., 20:34 UTC

Обсуждения рынка
Отчет

Global Equities Roundup: Market Talk

10 мар. 2026 г., 20:34 UTC

Обсуждения рынка
Отчет

Oracle Building More Software for Less Money After Restructuring -- Market Talk

10 мар. 2026 г., 20:23 UTC

Отчет

Oracle Stock Jumps on Earnings Beat -- Barrons.com

10 мар. 2026 г., 20:16 UTC

Отчет

NIO Stock Jumps After Earnings. How the EV Maker Delivered a Surprise Profit. -- Barrons.com

10 мар. 2026 г., 20:14 UTC

Отчет

Oracle Has Not Yet Initiated At-The-Market Equity Portion of Financing Program >ORCL

10 мар. 2026 г., 20:14 UTC

Отчет

Oracle Said In February It Intends to Raise Up to $50 B Dollars in Debt and Equity Financing >ORCL

10 мар. 2026 г., 20:13 UTC

Отчет

Oracle Raised $30 B Through Combination of Investment Grade Bonds and Mandatory Convertible Preferred Stk Within Days of Feb Announcement >ORCL

10 мар. 2026 г., 20:12 UTC

Отчет

Oracle Stock Jumps on Earnings Beat -- Barrons.com

Сравнение c конкурентами

Изменение цены

ICU Medical Inc Прогноз

Целевая цена

By TipRanks

34.24% рост

Прогноз на 12 месяцев

Средняя 179 USD  34.24%

Максимум 180 USD

Минимум 178 USD

Основано на мнении 3 аналитиков Wall Street, спрогнозировавших целевые цены для ICU Medical Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

3 ratings

2

Покупка

1

Удержание

0

Продажа

Техническая оценка

By Trading Central

137.16 / N/AПоддержка и Сопротивление

Краткосрочная

Very Strong Bullish Evidence

Среднесрочная

Bullish Evidence

Долгосрочная

Strong Bearish Evidence

Настроения

By Acuity

41 / 351Рейтинг в Здравоохранение

Новостные настроения

Сильные свидетельства восходящего тренда

Волатильность

Ниже среднего

Объем новостей (RCV)

Выше среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании ICU Medical Inc

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.
help-icon Live chat